ESR1 and neoplasm: For 2 patients with ER-negative (primary tumor) IHC results and ER-positive CTCs, their responses to endocrine therapy were good, revealing that the accuracy of utilizing ER status in CTCs to predict clinical treatment be 100% for these patients.